Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.20%9.38B | 8.38%8.75B | 7.59%2.24B | 12.81%2.3B | 6.56%2.13B | 6.47%2.07B | 4.67%8.08B | 5.14%2.08B | 2.04B | 2B |
| Cost of revenue | 7.64%5.09B | 4.96%4.73B | 11.18%1.28B | 5.19%1.2B | 2.97%1.15B | 0.24%1.1B | 4.12%4.5B | -1.63%1.15B | 1.14B | 1.11B |
| Gross profit | 6.68%4.3B | 12.69%4.03B | 3.16%964.8M | 22.51%1.1B | 11.05%989.23M | 14.52%972.79M | 5.38%3.57B | 14.85%935.2M | 897.48M | 890.77M |
| Operating expense | 5.22%3.14B | 9.25%2.99B | 9.35%773.22M | 11.13%742.79M | 6.21%737.26M | 10.42%733.38M | 5.03%2.73B | 5.88%707.12M | 668.41M | 694.18M |
| Operating profit | 10.88%1.15B | 23.92%1.04B | -16.01%191.57M | 55.73%356.74M | 28.17%251.97M | 29.21%239.41M | 6.55%839.03M | 55.78%228.08M | 229.07M | 196.59M |
| Net non-operating interest income (expenses) | -13.84%-42.54M | 39.63%-37.37M | 50.26%-9.57M | 13.28%-9.01M | 16.31%-9.3M | 55.14%-9.49M | -27.99%-61.9M | -57.01%-19.25M | -10.39M | -11.11M |
| Non-operating interest income | 169.64%453K | 90.91%168K | 453.33%83K | -54.84%14K | 90.63%61K | 0.00%10K | -12.00%88K | -44.44%15K | --31K | --32K |
| Non-operating interest expense | 14.53%42.99M | -13.62%37.53M | -8.20%9.66M | -13.40%9.02M | -15.79%9.36M | -16.69%9.5M | -10.23%43.45M | -14.00%10.52M | --10.42M | --11.11M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | 33,596.36%18.53M | --8.74M | --0 | --28K |
| Net investment income | 7.18%8.42M | -47.24%7.86M | 27.01%-6.77M | 121.73%989K | 31.85%8.04M | -75.27%5.59M | 4.72%14.89M | -9.27M | -4.55M | 6.1M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 150.61%50M | -98.8M | 0 | |||||||
| Income from associates and other participating interests | 37.45%45.24M | -18.07%32.91M | -29.54%7.67M | 1.95%10.41M | 22.78%13.06M | -78.94%1.78M | 6.46%40.17M | -16.69%10.88M | 10.21M | 10.64M |
| Special income (charges) | 156.57%169.76M | -226.21%-300.09M | -7,628.57%-500.65M | -97.99%3.6M | -89.57%4.72M | 2,882.22%192.23M | 2,070.94%237.77M | 120.68%6.65M | 179.39M | 45.29M |
| Less:Other special charges | -0.84%-216.18M | 9.84%-214.38M | -107.92%-13.83M | 97.99%-3.6M | 89.57%-4.72M | -2,882.22%-192.23M | -2,070.94%-237.77M | -120.68%-6.65M | ---179.39M | ---45.29M |
| Less:Write off | -90.98%46.42M | --514.48M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 244.29%73.38M | -31.27%21.31M | -7.61%11.17M | 51.06%4.93M | -46.94%6.86M | -160.18%-1.64M | -27.25%31.01M | -38.80%12.09M | 3.26M | 12.93M |
| Income before tax | 118.94%1.46B | -39.55%665.51M | -276.89%-405.38M | -9.66%367.66M | 5.73%275.36M | 109.36%427.88M | 34.01%1.1B | 70.00%229.18M | 407M | 260.44M |
| Income tax | 5.36%423.81M | 12.59%402.25M | -32.89%48.52M | 10.69%133.27M | 9.33%82.49M | 54.82%137.97M | 41.84%357.26M | 76.66%72.3M | 120.39M | 75.45M |
| Net income | 292.47%1.03B | -64.60%263.27M | -389.33%-453.9M | -18.22%234.39M | 4.26%192.87M | 151.54%289.91M | 30.54%743.72M | 67.09%156.88M | 286.6M | 184.99M |
| Net income continuous operations | 292.47%1.03B | -64.60%263.27M | -389.33%-453.91M | -18.22%234.39M | 4.26%192.87M | 151.54%289.91M | 30.54%743.72M | 67.09%156.88M | --286.6M | --184.99M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 292.47%1.03B | -64.60%263.27M | -389.33%-453.9M | -18.22%234.39M | 4.26%192.87M | 151.54%289.91M | 30.54%743.72M | 67.09%156.88M | 286.6M | 184.99M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 292.47%1.03B | -64.60%263.27M | -389.33%-453.9M | -18.22%234.39M | 4.26%192.87M | 151.54%289.91M | 30.54%743.72M | 67.09%156.88M | 286.6M | 184.99M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 292.15%87.88 | -70.10%22.41 | -354.78%-38.65 | -31.34%19.94 | -12.57%16.41 | 106.26%24.71 | -41.25%74.96 | 57.21%15.17 | 29.04 | 18.77 |
| Diluted earnings per share | 292.15%87.88 | -70.10%22.41 | -389.00%-38.65 | -31.01%19.9374 | -12.03%16.41 | 106.26%24.71 | -41.25%74.96 | 38.59%13.3737 | 28.8992 | 18.6531 |
| Dividend per share | 7.69%28 | 30.00%26 | 30.00%13 | 0 | 30.00%13 | 0 | 0.00%20 | 0.00%10 | 0 | 10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |